Affluent Medical | WebDisclosure

PRESS RELEASE

published on 01/05/2026 at 17:45, 2 months 21 days ago

Affluent Medical : Nombre d’actions composant le capital social et nombre total de droits de vote au 30.11.25.
Affluent Medical : Détails des droits de vote et actions au 30/11/25. Informations réglementaires conformes à l'article L. 233-8 II du code de commerce et à l'article 223-16 du règlement de l'AMF

Droits De Vote Capital Social AMF Affluent Medical Informations Réglementaires
BRIEF

published on 12/19/2025 at 18:01, 3 months 6 days ago

Affluent Medical va transformer les thérapies cardiovasculaires grâce à la formation de Carvolix

Médical Aisé Expansion Du Marché Acquisition De Carvolix Thérapies Pilotées Par L'IA Innovation Cardiovasculaire
BRIEF

published on 12/19/2025 at 18:01, 3 months 6 days ago

Affluent Medical devient Carvolix avec deux acquisitions

Acquisitions Affluent Medical Carvolix Thérapies Cardiovasculaires Mini-robotique
BRIEF

published on 12/19/2025 at 18:01, 3 months 6 days ago

Affluent Medical becomes Carvolix with two acquisitions

Acquisitions Medical Afflict Carvolix Cardiovascular Therapies Mini-robotics
BRIEF

published on 12/19/2025 at 18:01, 3 months 6 days ago

Affluent Medical to Transform Cardiovascular Therapies with Carvolix Formation

Affluent Medical Market Expansion AI-driven Therapies Cardiovascular Innovation Carvolix Acquisition
PRESS RELEASE

published on 12/19/2025 at 17:56, 3 months 6 days ago

Affluent Medical annonce l’acquisition prochaine de Caranx Medical et Artedrone et devient Carvolix, pionnier des thérapies cardiovasculaires.
Affluent Medical devient Carvolix en acquérant Caranx Medical et Artedrone, spécialisée en thérapies cardiovasculaires avec implants innovants et robots IA. Acquisitions sans décaissement et financement de 30 M€. Finalisation attendue d'ici fin janvier 2026

Acquisition Affluent Medical Implants Innovants Carvolix Thérapies Cardiovasculaires
PRESS RELEASE

published on 12/19/2025 at 17:56, 3 months 6 days ago

Affluent Medical announces upcoming acquisition of Caranx Medical and Artedrone, becoming Carvolix, pioneering cardiovascular therapies.
Affluent Medical announces acquisition of Caranx Medical and Artedrone to form Carvolix, leading in cardiovascular therapies with AI-driven mini-robots and implants. Funding secured for innovative products

Acquisition Affluent Medical Carvolix Cardiovascular Therapies AI-driven Mini-robots
BRIEF

published on 11/05/2025 at 17:50, 4 months 21 days ago

Affluent Medical : Capital Social et Droits de Vote au 31 Octobre 2025

Euronext Paris Droits De Vote Capital Social Réglementation Affluent Medical
BRIEF

published on 11/05/2025 at 17:50, 4 months 21 days ago

Affluent Medical: Share Capital and Voting Rights as of October 31, 2025

Euronext Paris Share Capital Voting Rights Regulation Medical Afflict
BRIEF

published on 11/05/2025 at 17:50, 4 months 21 days ago

Affluent Medical : Informations sur le Capital Social et les Droits de Vote

Euronext Paris Droits De Vote Capital Social Regulation Affluent Medical

Published on 03/26/2026 at 16:20, 1 hour 33 minutes ago

ACCESS Newswire Upgrades the ACCESS Platform to Include Social Monitoring to Track Brand Conversations Across Major Social Platforms
Published on 03/26/2026 at 14:05, 3 hours 48 minutes ago

SouthGobi Announces Profit Warning
Published on 03/26/2026 at 13:00, 4 hours 53 minutes ago

Prospect Ridge Strengthens Technical Team with Appointment of Phil Smerchanski as Senior Technical Advisor
Published on 03/26/2026 at 13:00, 4 hours 53 minutes ago

GameSquare's Stream Hatchet Launches Creator Communities to Manage the Full Creator Marketing Lifecycle
Published on 03/26/2026 at 12:59, 4 hours 54 minutes ago

Adcore Concludes Fiscal Year 2025 With Strong Q4 Performance

View all ACCESSWIRE

Published on 03/26/2026 at 17:45, 8 minutes ago

CTS EVENTIM exceeds EUR 3 billion in revenue for the first time, sustaining profitable growth
Published on 03/26/2026 at 17:20, 32 minutes ago

EQS-Adhoc: Leifheit Aktiengesellschaft: Board of Management and Supervisory Board propose to the Annual General Meeting a capital increase from the company’s own funds, followed by an ordinary capital reduction
Published on 03/26/2026 at 17:19, 33 minutes ago

Haier Smart Home Reports Full-Year 2025 Results: Global Revenue Surpasses RMB 300 Billion for the First Time; Net Profit Reaches a Record Highs
Published on 03/26/2026 at 17:13, 39 minutes ago

Custodian Property Income REIT plc: Share Buyback
Published on 03/26/2026 at 17:03, 49 minutes ago

RM plc: 2025 Annual Report and Financial Statements and 2026 Annual General Meeting

View all EQS

Published on 03/26/2026 at 17:45, 8 minutes ago

Cegedim : poursuite de l’amélioration de la rentabilité
Published on 03/26/2026 at 17:45, 8 minutes ago

Cegedim: profitability continues to improve
Published on 03/26/2026 at 08:57, 8 hours 55 minutes ago

Communiqué Edenred
Published on 03/26/2026 at 08:57, 8 hours 55 minutes ago

Edenred statement
Published on 03/26/2026 at 07:30, 10 hours 23 minutes ago

BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY

View all LES ECHOS COMFI WIRE

News